CARE Ratings Q1 FY26 earnings call: Revenue & Margins

The investor presentation does not explicitly mention any specific capex, capacity expansion, or new plant/project undertaken by CARE Ratings Limited or its subsidiaries. However, it does provide macro-level insights on the Indian economy relevant to capex: - Government’s thrust on capex highlighted with Gross Fixed Capital Formation growth at 7.1% in FY25 (Page 11). - Centre’s capex-to-GDP budgeted at 3.1% in FY26, up from 1.7% during FY15-19 (Page 11). - Investment growth mainly driven by government capex focus; private capex revival remains uncertain (Page 3). No specific company-level capital expenditure, plant expansions, or new project investments with amounts, status, or timelines are detailed in the presentation. The focus is on economic conditions supporting capex broadly, not on CARE Ratings’ direct capex activities.

The investor presentation does not report any details on order book, order inflow, or pending orders. - There is no mention or data related to order book, order inflow, or pending orders anywhere in the 22-page presentation. - The document primarily focuses on financial results, business segments, growth metrics, outreach activities, market environment indicators, credit growth, capex trends, and corporate bond issuances. - No slides or sections contain information regarding order volumes, order backlogs, or order inflows for CARE Ratings Limited or its subsidiaries.